Grindeks JSC, Pharmstandard deal

Pharmstandard acquired an 11.3% stake in Grindeks, or about 1.1 million shares, on April 9. Grindeks' branded prescription and OTC drugs are marketed in about 40 countries and had 2009 revenues of LVL...